P. Westeel

发表

Insulin maintains plasma antioxidant capacity at an early phase of kidney transplantation.

G. Choukroun, A. Fournier, H. Mazouz, 2007, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Low incidence of SARS-CoV-2, risk factors of mortality and the course of illness in the French national cohort of dialysis patients

E. M. Passos, L. Duflot, M. Brahimi, 2020, Kidney International.

Treating diabetes with islet transplantation: lessons from the past decade in Lille.

F. Pattou, E. Thervet, R. Caiazzo, 2014, Diabetes & metabolism.

Access to preemptive registration on the waiting list for renal transplantation: a hierarchical modeling approach

G. Launoy, M. Hazzan, B. Hurault de Ligny, 2015, Transplant international : official journal of the European Society for Organ Transplantation.

Hemodialysis in the treatment of lactic acidosis in diabetics treated by metformin: a study of metformin elimination.

A. Fournier, M. Andréjak, J. Lalau, 1989, International journal of clinical pharmacology, therapy, and toxicology.

Levels of Indoxyl Sulfate in Kidney Transplant Patients, and the Relationship With Hard Outcomes.

Z. Massy, R. Vanholder, G. Choukroun, 2016, Circulation journal : official journal of the Japanese Circulation Society.

A 50% reduction in cyclosporine exposure in stable renal transplant recipients: renal function benefits.

P. Marquet, O. Toupance, B. Hurault de Ligny, 2010, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Preventing renal bone disease in moderate renal failure with CaCO3 and 25(OH) vitamin D3.

A. Fournier, J. Sebert, J. Guéris, 1988, Kidney international. Supplement.

Risk factors of renal failure progression two years prior to dialysis.

J. Achard, A. Fournier, I. Kacsó, 1999, Clinical nephrology.

Non-aluminic adynamic bone disease in non-dialyzed uremic patients: a new type of osteopathy due to overtreatment?

B. Boudailliez, A. Fournier, J. Sebert, 1992, Bone.

Early Acute Microvascular Kidney Transplant Rejection in the Absence of Anti-HLA Antibodies Is Associated with Preformed IgG Antibodies against Diverse Glomerular Endothelial Cell Antigens.

S. Satchell, N. Kamar, P. Gatault, 2019, Journal of the American Society of Nephrology : JASN.

Anglicheau, D. (2019). Early acute microvascular kidney transplant rejection in the absence of anti-HLA antibodies is associated with preformed IgG

P. Gatault, N. Arzouk, M. Giral, 2019 .

One-year Results of the Effects of Rituximab on Acute Antibody-Mediated Rejection in Renal Transplantation: RITUX ERAH, a Multicenter Double-blind Randomized Placebo-controlled Trial

O. Toupance, C. Pouteil‐Noble, P. Lang, 2016, Transplantation.

Absence of Mortality Differences Between the First and Second COVID-19 Waves in Kidney Transplant Recipients

N. Kamar, L. Frimat, P. Gatault, 2022, Kidney International Reports.

Efficacy on Renal Function of Early Conversion from Cyclosporine to Sirolimus 3 Months After Renal Transplantation: Concept Study

E. Thervet, O. Toupance, Y. Meur, 2009, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Renal osteodystrophy in dialysis patients: diagnosis and treatment.

B. Boudailliez, J. Achard, A. Fournier, 1998, Artificial organs.

Efficacy and safety of de novo or early everolimus with low cyclosporine in deceased‐donor kidney transplant recipients at specified risk of delayed graft function: 12‐month results of a randomized, multicenter trial

F. Berthoux, L. Rostaing, S. Quéré, 2010, Transplant international : official journal of the European Society for Organ Transplantation.

Incidence of Delayed Graft Function and Wound Healing Complications After Deceased-Donor Kidney Transplantation Is not Affected by De Novo Everolimus

F. Berthoux, L. Rostaing, O. Toupance, 2009, Transplantation.

The association between killer‐cell immunoglobulin‐like receptor (KIR) and KIR ligand genotypes and the likelihood of BK virus replication after kidney transplantation

S. Castelain, G. Choukroun, C. Presne, 2016, Transplant international : official journal of the European Society for Organ Transplantation.

Diet, vitamin D and vertebral mineral density in hypercalciuric calcium stone formers.

B. Boudailliez, C. Bergot, J. Achard, 1991, Kidney international.

Drug Insight: renal indications of calcimimetics

Z. Massy, G. Choukroun, A. Fournier, 2006, Nature Clinical Practice Nephrology.

A case of pseudo-Nelson’s syndrome: cure of ACTH hypersecretion by removal of a bronchial carcinoid tumor responsible for Cushing’s syndrome

D. Vieau, F. Lenne, J. Lalau, 1990, Journal of endocrinological investigation.

The captopril challenge test as a screening test for renovascular hypertension.

B. Boudailliez, A. Fournier, P. Fiévet, 1988, Kidney international. Supplement.

Magnesium hydroxide as a complementary aluminium-free phosphate binder to moderate doses of oral calcium in uraemic patients on chronic haemodialysis: lack of deleterious effect on bone mineralisation.

A. Fournier, P. Morinière, P. Westeel, 1988, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Disappearance of aluminic bone disease in a long term asymptomatic dialysis population restricting A1(OH)3 intake: emergence of an idiopathic adynamic bone disease not related to aluminum.

B. Boudailliez, P. Fiévet, J. Sebert, 1989, Nephron.

[Cutaneous T-cell lymphoma following renal transplantation].

C. Lok, E. Carmi, P. Westeel, 2003, Annales de dermatologie et de venereologie.

[Comparison of calcium acetate and calcium carbonate for the control of predialysis hyperphosphatemia].

J. Achard, A. Fournier, P. Morinière, 1991, Nephrologie.

Use of Highly Individualized Complement Blockade Has Revolutionized Clinical Outcomes after Kidney Transplantation and Renal Epidemiology of Atypical Hemolytic Uremic Syndrome.

F. Petitprez, Z. Massy, C. Charasse, 2019, Journal of the American Society of Nephrology : JASN.

Prognostic Value of the Persistence of C1q-Binding Anti-HLA Antibodies in Acute Antibody-Mediated Rejection in Kidney Transplantation

P. Grimbert, P. Gatault, Y. Lebranchu, 2017, Transplantation.

Favorable outcome under simple heparin therapy of recurrent anuria due to graft renal vein thrombosis and subcapsular hematoma.

J. Achard, A. Fournier, B. Tribout, 1993, Transplantation proceedings.

Impact of targeted hypothermia in expanded-criteria organ donors on recipient kidney-graft function: study protocol for a multicentre randomised controlled trial (HYPOREME)

K. Asehnoune, L. Rostaing, A. Heng, 2022, BMJ Open.

Immunosuppressant Regimen Based on Sirolimus Decreases Aortic Stiffness in Renal Transplant Recipients in Comparison to Cyclosporine

E. Thervet, Y. Lebranchu, I. Étienne, 2011, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Efficacy and Safety of Early Cyclosporine Conversion to Sirolimus with Continued MMF—Four‐Year Results of the Postconcept Study

E. Thervet, O. Toupance, Y. Lebranchu, 2011, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Renal and Hypertensive Complications of Extracorporeal Shock Wave Lithotripsy: Who Is at Risk?

J. Achard, A. Fournier, P. Westeel, 1999, Urologia Internationalis.

La lithiase urinaire. I

J. Achard, P. Morinière, P. Westeel, 1992 .

IMPact of the COVID-19 epidemic on the moRTAlity of kidney transplant recipients and candidates in a French Nationwide registry sTudy (IMPORTANT)

J. Dumortier, A. Heng, N. Kamar, 2020, Kidney International.

Adherence profiles in kidney transplant patients: Causes and consequences.

P. Marquet, N. Kamar, M. Essig, 2019, Patient education and counseling.

Individualized Mycophenolate Mofetil Dosing Based on Drug Exposure Significantly Improves Patient Outcomes After Renal Transplantation

P. Marquet, L. Rostaing, E. Thervet, 2007, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Use of alkaline calcium salts as phosphate binder in uremic patients.

J. Achard, A. Fournier, P. Morinière, 1992, Kidney international. Supplement.

Bicarbonate haemodialysis: an adequate treatment for lactic acidosis in diabetics treated by metformin

A. Fournier, J. Lalau, X. Debussche, 2004, Intensive Care Medicine.

Control of a relapse and induction of long-term remission of Wegener's granulomatosis by cyclosporine.

K. Lassoued, A. Fournier, I. Henry, 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Post-transplantation lymphoproliferative disorder after kidney transplantation: report of a nationwide French registry and the development of a new prognostic score.

R. Porcher, A. Heng, O. Toupance, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

J. Achard, A. Fournier, J. Lalau, 2005, Intensive Care Medicine.

CMV infections after two doses of daclizumab versus thymoglobulin in renal transplant patients receiving mycophenolate mofetil, steroids and delayed cyclosporine A.

O. Toupance, J. Goujon, Y. Le Meur, 2008, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Is COVID-19 infection more severe in kidney transplant recipients?

N. Kamar, L. Frimat, P. Grimbert, 2020, American Journal of Transplantation.

Pronase treatment improves flow cytometry crossmatching results

G. Choukroun, P. Westeel, M-J Apithy, 2017, HLA.

Hemolytic-uremic syndrome after cancer chemotherapy without mitomycin C.

A. Fournier, P. Fiévet, P. Westeel, 1986, Nephron.

The influence of cytomegalovirus infections on patient and renal graft outcome: a 3-year, multicenter, observational study (Post-ECTAZ Study).

O. Toupance, B. Hurault de Ligny, Y. Le Meur, 2011, Transplantation proceedings.

Multiple Clustered Dermatofibromas on a Superficial Venous Thrombosis in a Kidney-Transplanted Patient

C. Lok, F. Agbalika, P. Westeel, 2004, Dermatology.

Characteristics of T- and NK-cell Lymphomas After Renal Transplantation: A French National Multicentric Cohort Study

P. Gaulard, G. Salles, P. Rieu, 2021, Transplantation.

The FcγRIIIA‐158 VV genotype increased the risk of post‐transplant lymphoproliferative disorder in T‐cell‐depleted kidney transplant recipients – a retrospective study

P. Marquet, V. Gouilleux-Gruart, N. Kamar, 2020, Transplant international : official journal of the European Society for Organ Transplantation.

Prevention of hyperparathyroidism in patients on maintenance dialysis by intravenous 1-alpha-hydroxyvitamin D3 in association with Mg(OH)2 as sole phosphate binder. A randomized comparative study with the association CaCO3 +/- Mg(OH)2.

B. Boudailliez, R. Bouillon, J. Achard, 1992, Nephron.

Indirect clinical evidence that 1 alpha OH vitamin D3 increases the intestinal absorption of aluminum.

B. Boudailliez, A. Fournier, P. Westeel, 1989, Clinical nephrology.

An initial report from the French SOT COVID Registry suggests high mortality due to COVID-19 in recipients of kidney transplants

J. Dumortier, A. Heng, N. Kamar, 2020, Kidney International.

Prevention of osteitis fibrosa, aluminium bone disease and soft-tissue calcification in dialysis patients: a long-term comparison of moderate doses of oral calcium +/- Mg(OH)2 vs Al(OH)3 +/- 1 alpha OH vitamin D3.

B. Boudailliez, A. Fournier, P. Morinière, 1989, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Renal artery aneurysm secondary to Candida albicans in four kidney allograft recipients.

Y. Lebranchu, C. Noel, M. Buchler, 2005, Transplantation proceedings.

[Results of nephrectomy for native kidney tumors in renal transplanted patients].

F. Saint, P. Westeel, X. Tillou, 2011, Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie.

De novo renal carcinoma in renal transplant recipients: effect of early treatment.

F. Saint, P. Westeel, X. Tillou, 2009, Transplantation proceedings.

Plasma atrial natriuretic factor and urinary excretion of a ouabain displacing factor and dopamine in normotensive pregnant women before and after delivery.

J. Gondry, P. Fiévet, J. Lalau, 1990, American journal of obstetrics and gynecology.

PRELIMINARY RESULTS OF A RANDOMIZED TRIAL COMPARING SIROLIMUS (SRL) VERSUS CYCLOSPORINE (CSA) IN 150 TRANSPLANT PATIENTS RECEIVING A CADAVERIC RENAL GRAFT

O. Toupance, P. Deteix, Y. Lebranchu, 2004 .

Alternative phosphate binders for aluminium hydroxide

B. Boudailliez, A. Fournier, J. Lalau, 1990 .

Higher exposure to mycophenolic acid with sirolimus than with cyclosporine cotreatment

P. Marquet, A. Heng, Y. Lebranchu, 2005, Clinical pharmacology and therapeutics.

[Renal and hypertensive complications of extracorporeal lithotripsy].

J. Achard, A. Fournier, P. Westeel, 2000, Presse medicale.

An extension of the RITUX‐ERAH study, multicenter randomized clinical trial comparing rituximab to placebo in acute antibody‐mediated rejection after renal transplantation

N. Kamar, C. Pouteil‐Noble, P. Grimbert, 2020, Transplant international : official journal of the European Society for Organ Transplantation.

1-alpha-Hydroxyvitamin D3 derivatives in the treatment of renal bone diseases: justification and optimal modalities of administration.

B. Boudailliez, A. Fournier, H. Mazouz, 1995, Nephron.

Atrial natriuretic factor in pregnancy-induced hypertension and preeclampsia: increased plasma concentrations possibly explaining these hypovolemic states with paradoxical hyporeninism.

A. Fournier, P. Fiévet, A. D. de Bold, 1988, American journal of hypertension.

Non-invasive detection of pulmonary hypertension prior to renal transplantation is a predictor of increased risk for early graft dysfunction

J. Benichou, P. Marquet, O. Toupance, 2010 .

[Blood gas and acid-base changes and rhythmologic tolerance of acetate and bicarbonate hemodialysis using a standard dialyser with high sodium and control of ultrafiltration].

A. Fournier, P. Fiévet, P. Morinière, 1983, Nephrologie.

Atrial natriuretic factor in pregnancy and pregnancy-induced hypertension.

A. Fournier, P. Fiévet, J. Lalau, 1991, Canadian journal of physiology and pharmacology.

Merkel cell carcinoma from renal transplant recipients are mostly MCPyV‐negative and are frequently associated with squamous cell carcinomas or precursors

L. Doucet, C. Collin, P. Gatault, 2023, Journal of the European Academy of Dermatology and Venereology : JEADV.

Changing of therapeutic trends between the 1st and 2nd wave did not reduce COVID-19 related mortality of renal transplant recipients: a national registry study.

N. Kamar, L. Frimat, P. Gatault, 2021, medRxiv.

Clinical Utility of Biochemical Markers for the Prediction of COVID-19−Related Mortality in Kidney Transplant Recipients

J. Dumortier, A. Heng, N. Kamar, 2021, Kidney International Reports.

Control of predialytic hyperphosphatemia by oral calcium acetate and calcium carbonate. Comparable efficacy for half the dose of elemental calcium given as acetate without lower incidence of hypercalcemia.

B. Boudailliez, J. Achard, A. Fournier, 1992, Nephron.

COMPARISON AT ONE YEAR OF INTERSTITIAL FIBROSIS (IF) BY AUTOMATIC QUANTIFICATION IN RENAL TRANSPLANT RECIPIENTS (RTR) WITH CYCLOSPORINE (CSA) DISCONTINUATION AND SIROLIMUS (SRL) INTRODUCTION: 450

V. Meas-Yedid, E. Thervet, A. Servais, 2008 .

Erosive osteoarthropathy associated with beta 2-microglobulin amyloidosis in a uraemic patient treated exclusively by long-term haemofiltration with biocompatible membranes.

A. Fournier, J. Sebert, P. Morinière, 1988, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[Thrombotic thrombocytopenic purpura and hemolytic-uremic syndrome in adults. Apropos of 27 cases].

A. Fournier, B. Tribout, P. Westeel, 1997, Annales de medecine interne.

[Long-term stability of bone mineral density in patients with renal transplant treated with cyclosporine and low doses of corticoids. Protective role of cyclosporine?].

A. Fournier, H. Mazouz, J. Sebert, 1998, Presse medicale.

Captopril prevention project--what shall we do about captopril and the risk of stroke?

J. Achard, A. Fournier, H. Mazouz, 2000, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Correlation between Luminex donor-specific crossmatches and levels of donor-specific antibodies in pretransplantation screening.

C. Presne, P. Westeel, N. Guillaume, 2013, Tissue antigens.

Therapeutic education as a tool to improve patient‐reported and clinical outcomes after renal transplantation: results of the EPHEGREN multicenter retrospective cohort study

P. Marquet, N. Kamar, I. Étienne, 2021, Transplant international : official journal of the European Society for Organ Transplantation.

The influence of cytomegalovirus infections on patient and renal graft outcome: a 3-year, multicenter, observational study (Post-ECTAZ Study).

O. Toupance, Y. Meur, P. Westeel, 2011, Transplantation proceedings.

Management of hyperphosphatemia in patients with renal failure.

A. Fournier, P. Westeel, A. Ghazali, 1993, Current opinion in nephrology and hypertension.